Document:

EX-4.05

 Exhibit 4.05 

 
 

 
 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933 AS AMENDED (the “1933 ACT”), OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO YOU THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE 1933 ACT, OR ANY APPLICABLE STATE SECURITIES LAWS. 

PLAIN ENGLISH WARRANT AGREEMENT 
 This is a PLAIN ENGLISH WARRANT AGREEMENT dated April 24, 2009 by and between CHEGG, INC., a Delaware corporation, and TRIPLEPOINT CAPITAL LLC, a Delaware limited liability company.

 The words “We”, “Us”, or “Our” refer to the warrant holder, which is TRIPLEPOINT CAPITAL LLC. The words
“You” or “Your” refers to the issuer, which is CHEGG, INC., and not to any individual. The words “The Parties” refers to both TRIPLEPOINT CAPITAL LLC and CHEGG, INC. This Plain English Warrant Agreement may be referred
to as the “Warrant Agreement”. 
 The Parties have entered into a Plain English Revolving Loan and Security Agreement dated as of
April 24, 2009, the “Loan Agreement”. 
 In consideration of such Loan Agreement, the Parties agree to the following mutual
agreements and conditions set forth below: 
  

					
	WARRANT INFORMATION
	 	 	 
	
Effective Date
	 	 Warrant Number
	 	 Loan Facility
Number

	April 24, 2009	 	0592-W-01	 	0592-RV-01

							
	
Warrant Coverage
	 	 Number of Shares
	 	 Price Per Share
	 	 Type of
Stock

	$135,000 (6.75% of $2,000,000) shall be
earned upon the Closing Date (as defined in the Loan Agreement); up to an additional $202,500 (6.75% of $3,000,000) shall be earned based upon cumulative Advances under the Loan Agreement which exceed $2,000,000	 	 115,793 upon the Closing Date; up to an
additional 173,690 based upon cumulative Advances under the Loan Agreement which exceed $2,000,000
  

(*Subject to adjustment per the terms of this Warrant Agreement)
	 	 $1.1658706

 
  
  

 
  

(*Subject to adjustment per the terms of this Warrant Agreement)
	 	 Series C-2 Preferred
Stock
  
  
  

 
  

(*Subject to adjustment per the terms of this Warrant Agreement)

  

					
	OUR CONTACT
INFORMATION
	 	 	 
	
Name
	 	 Address For Notices
	 	 Contact
Person

	TriplePoint Capital LLC	 	 2755 Sand Hill Road, Ste.
150
 Menlo Park, CA 94025
 Tel: (650) 854-2090
 Fax: (650) 854-1850
	 	 Sajal
Srivastava, COO
 Tel: (650) 233-2102
 Fax: (650) 854-1850
 email: legal@triplepointcapital.com

	 
	YOUR
 CONTACT INFORMATION
	 	 	 
	
Customer Name
	 	 Address For Notices
	 	 Contact
Person

	Chegg, Inc.	 	 4655 Old Ironsides Dr., Suite
350
 Santa Clara, CA 95054
	 	 Omer Regev,
CFO
 Tel: (408) 727-6486
 Fax: (501) 423-7297
 email: omer@chegg.com

  

	1.	WHAT YOU AGREE TO GRANT US 

 You grant to
Us and We are entitled, upon the terms and subject to the conditions set forth in this Warrant Agreement, to purchase from You, at a price per share equal to the Exercise Price, that number of fully paid and non-assessable shares of Your Warrant
Stock equal to One Hundred Thirty Five Thousand and No/100 Dollars ($135,000), divided by the Exercise Price. 
 In addition, immediately upon
cumulative Advances made by Us to You under the Loan Agreement in excess of Two Million and No/100 Dollars ($2,000,000), You grant to Us and We are entitled, upon the terms and subject to the conditions set forth in this Warrant Agreement, to
purchase from You, at a price per share equal to the Exercise Price, an additional number of fully paid and non-assessable shares of Your Warrant Stock equal to six and three quarters percent (6.75%) of any amounts advanced under the Loan
Agreement in excess of Two Million and No/100 Dollars ($2,000,000), divided by the Exercise Price. For purposes of the above calculation, the Warrant Coverage shall be based upon the sum of cumulative Advances without consideration to any prepayment
made by You during the Loan Term (as defined in the Loan Agreement). 
 For the avoidance of doubt, the maximum amount of Warrant Coverage which
may be earned under this Warrant Agreement is $337,500. 
 The number of shares of Warrant Stock and the Exercise Price of such Warrant Stock
are subject to adjustment as provided in Section 4 hereof. 
 For purposes of this Warrant Agreement, the following capitalized terms have
the meanings given below: 
 “Exercise Price” means the lower of (a) 1.1658706 and (b) the lowest per share
price for which Your preferred stock is sold in the Next Round. 
 “Next Round” means the next bona fide round of
equity financing in which You issue and sell shares of your preferred stock (anticipated to be Your Series D Preferred Stock) for aggregate gross cash proceeds of at least $1,000,000 (excluding any amounts received upon conversion or cancellation of
indebtedness) subsequent to the Effective Date. 
 “Warrant Stock” means (a) the class and series of Your
preferred stock issued in the Next Round, if the lowest per share price for which such preferred stock is sold in the Next Round is less than 1.1658706, or (b) in all other cases, Your Series C-2 Preferred Stock. For avoidance of doubt, if this
Warrant Agreement is exercised prior to the Next Round then this Warrant Agreement shall be exercisable for Your Series C-2 Preferred Stock. 

The Parties agree that this Warrant Agreement to purchase the Warrant Stock has a fair market value equal to $100 and that $100 of the issue price of the
investment will be allocable to the Warrant Agreement and the balance shall be allocable to the Loan Agreement for income tax purposes and the original issue discount on the Loan Agreement shall be considered to be zero. 

 

	2.	WHEN ARE WE ENTITLED TO PURCHASE YOUR WARRANT STOCK. 

 The term of this Warrant Agreement and our right to purchase Warrant Stock will begin the Effective Date, and shall be available for the greater of (i) 7 years from the Effective Date or (ii) 5
years from the effective date of Your initial public offering. 
 Notwithstanding the foregoing, Our right to purchase the Warrant Stock shall
be automatically and fully exercised via the net issuance method described below (without surrender of the Warrant Agreement) upon the occurrence of a Merger Event, as defined below, with a Person that is not one of Your affiliates, in which Your
common stock is exchanged for one or more of (i) cash or (ii) if Your are acquired by a publicly traded acquirer and the total per share consideration of the publicly traded Warrant stock (or other publicly traded securities issuable upon
exercise of this Warrant) is equal to or greater than three (3) times the aggregate Exercise Price (as adjusted). No less than ten (10) 

  
 2 

 
business days prior to any Merger Event, You shall provide Us with written notice of the proposed Merger Event together with a copy of the executed merger agreement, or other definitive
documentation (and all schedules and exhibits thereto) and information concerning Your expected capitalization immediately prior to the Merger Event. Upon consummation of the Merger Event, You shall promptly provide Us with (a) a copy of any
modifications or amendments to the executed merger agreement, (b) any other documents in connection therewith, (c) updated information, if any, concerning Your capitalization immediately prior to the Merger Event, and, (d) upon
request, by Us any other information reasonably necessary to an informed evaluation of Our rights under this Agreement. In such Merger Event, if the consideration to be received by Us does not consist of cash or publicly traded stock that is traded
on a recognized public exchange or the publicly traded stock is less than three (3) times the aggregate Exercise Price and We have not elected to exercise Our rights under this Warrant Agreement, then You may, at Your sole discretion, pay Us a
sum equal to three (3) times the Exercise Price for each share exercisable under this Warrant Agreement in exchange for the cancellation of this Warrant Agreement upon the consummation of the Merger Event 

 

	3.	HOW WE MAY PURCHASE YOUR WARRANT STOCK. 

We may exercise Our purchase rights, in whole or in part, at any time, or from time to time, prior to the expiration of the term of this Warrant
Agreement, by giving You a completed and executed Notice of Exercise in the form attached as Exhibit I. Promptly upon receipt of the Notice of Exercise and in any event no later than twenty-one (21) days after you have received
Our Notice of Exercise and payment of the aggregate Exercise Price for the shares purchased, You will issue to Us a certificate for the number of shares of Warrant Stock that We have purchased and You will execute the Acknowledgment of
Exercise in the form attached hereto as Exhibit II indicating the number of shares which will be available to Us for future purchases, if any. 
 We may pay for the Warrant Stock by either (i) cash or check, or (ii) by the net issuance method as determined below. If We elect the Net Issuance method, You will issue Warrant Stock using the
following formula: 
  

					
	X =	 	 Y(A-B)
	  	
		 	A	  	

  

					
	Where:	 	X =	  	 the number of shares of Warrant Stock to be issued to Us.

		 	Y =	  	 the number of shares of Warrant Stock We request to be exercised under this Warrant Agreement.

		 	A =	  	 the fair market value of one share of Warrant Stock.

		 	B =	  	 the Exercise Price.

 For purposes of the above calculation, current fair market value of Warrant Stock shall mean with respect to each share
of Warrant Stock: 
 If the exercise is in connection with the initial public offering of Your Common Stock, and if Your registration
statement relating to such public offering has been declared effective by the SEC, then the fair market value per share shall be the product of (x) the initial “Price to Public” specified in the final prospectus of the offering and
(y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise; 
 If this
Warrant Agreement is exercised after, and not in connection with Your initial public offering, and: 
  

	•	 	 if traded on a securities exchange, the fair market value shall be the product of (x) the average of the closing prices over a five (5) day
period ending three (3) days before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such
exercise; or 

  

	•	 	 if actively traded over-the-counter, the fair market value shall be the product of (x) the average of the closing bid and asked prices quoted on
the NASDAQ system (or similar system) over the five (5) day period ending three (3) days before the day the current fair market value of the securities is being determined and (y) the

  
 3 

	 	 
number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise. 

 If this Warrant Agreement is exercised prior to or after Your initial public offering, and: 
  

	•	 	 Your Common Stock is not listed on any securities exchange or quoted in the NASDAQ System or the over-the-counter market, the current fair market value
of Warrant Stock shall be the product of (x) the fair market value of a share of Your Common Stock (the highest price per share which You could obtain from a willing buyer (not a current employee or director) for shares of Common Stock sold,
from authorized but unissued shares), as determined in good faith by Your Board of Directors and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise, unless You shall
become subject to a merger, acquisition or other consolidation pursuant to which You are not the surviving party, in which case the fair market value of Warrant Stock shall be deemed to be the value received by the holders of Your Warrant Stock on a
common equivalent basis pursuant to such merger or acquisition or other consolidation. 

 During the term of this Warrant
Agreement, You will at all times from and after the Effective Date have authorized and reserved a sufficient number of shares of (a) Warrant Stock to provide for the exercise of our rights to purchase Warrant Stock, and (b) Common Stock to
provide for the conversion of the Warrant Stock. 
 If We elect to exercise part of the Warrant Agreement, You will promptly issue to Us an
amended Warrant Agreement stating the remaining number of shares that are available. All other terms and conditions of that amended Warrant Agreement shall be identical to those contained in this Warrant Agreement. 

If at the end of the term of this Warrant Agreement (as set forth in the first paragraph of Section 2), the fair market value of one share of
Warrant Stock (or other security issuable upon the exercise hereof) as determined in accordance herewith is greater than the Exercise Price in effect on such date, then this Warrant Agreement shall automatically be deemed on and as of such date to
be converted pursuant hereto as to all shares of Warrant Stock (or such other securities) for which it shall not previously have been exercised or converted, and You shall promptly deliver a certificate representing the shares of Warrant Stock (or
such other securities) issued upon such conversion to Us. 
  

	4.	WHEN WILL THE NUMBER OF SHARES AND EXERCISE PRICE CHANGE. 

  

	•	 	 If You are Acquired. If at any time (i) there is a reorganization of Your stock (other than a reclassification, exchange or subdivision of
Your stock otherwise provided for in this Warrant Agreement); (ii) You merge or consolidate with or into another entity, whether or not You are the surviving entity; or (iii) You sell or convey, or grant an exclusive license with respect
to, all or substantially all of Your assets to any other person; or (iv) there occurs any transaction or series of related transactions that result in the transfer of fifty percent (50%) or more of the outstanding voting power of the
capital stock of You (each of the foregoing events are referred to as a “Merger Event”), then, as a part of such Merger Event, lawful provision shall be made so that We shall thereafter be entitled to receive, upon exercise of Our rights
under this Warrant Agreement, the number of shares of preferred stock or other securities of the successor or surviving person resulting from such Merger Event, equal in value to that which would have been issuable if We had exercised Our rights
under this Warrant Agreement immediately prior to the Merger Event. In any such case, appropriate adjustment (as determined in good faith by Your Board of Directors) shall be made in the application of the provisions of this Warrant Agreement with
respect to Our rights and interest after the Merger Event so that the provisions of this Warrant Agreement (including adjustments of the Exercise Price and number of shares of Warrant Stock purchasable) shall be applicable to the greatest extent
possible. 

  

	•	 	 If You Reclassify Your Stock. If at any time You combine, reclassify, exchange or subdivide Your securities or otherwise, change any of the
securities as to which purchase rights under this Warrant Agreement exist into the same or a different number of securities of any other class or classes (including, without limitation, as a result of the automatic conversion of the Series C
Preferred Stock into Common Stock in accordance with Your certificate of incorporation), this Warrant Agreement will thereafter represent the right to acquire such number 

  
 4 

	 	 
and kind of securities as would have been issuable as the result of such change with respect to the securities which were subject to the purchase rights under this Warrant Agreement immediately
prior to such combination, reclassification, exchange, subdivision or other change. 

  

	•	 	 If You Subdivide or Combine Your Shares. If at any time You combine or subdivide Your Series C-2 Preferred Stock, the Exercise Price will be
proportionately decreased in the case of a subdivision, or proportionately increased in the case of a combination. 

  

	•	 	 If You Pay Stock Dividends. If at any time You pay a dividend payable in, or make any other distribution (except any distribution specifically
provided for in the above paragraphs) of Your Series C Preferred Stock, You will make sure that We will get that benefit of that stock dividend or distribution when we exercise this Warrant as if we had exercised the Warrant when the distribution of
Your Series C Preferred Stock was originally made. 

  

	•	 	 If You Change the Antidilution Rights of the Warrant Stock or Issue New Preferred or Convertible Stock. All antidilution rights applicable to
the Warrant Stock purchasable under this Warrant Agreement are as set forth in Your Certificate of Incorporation, as amended through the Effective Date. You will use commercially reasonable efforts to promptly provide Us with any restatement,
amendment, modification of or waiver of any right under Your Certificate of Incorporation provided, that if with commercially reasonable efforts You cannot promptly provide Us with such documents, You shall provide them within ten (10) days of
Our request. You will also use commercially reasonable efforts to provide Us with copies of any notices that You send to holders of the Warrant Stock with respect to any issuance of Your stock or other equity security to occur after the Effective
Date (other than issuances of stock or equity securities pursuant to customary employee stock plans) , provided, that if with commercially reasonable efforts You cannot promptly provide Us with such notices, You shall provide them within ten
(10) days of Our request. Notwithstanding any term or condition contained in this Warrant Agreement, the Loan Agreement to the contrary, Your failure to comply with this paragraph shall not constitute an Event of Default unless You have not
provided the information requested within ten (10) days of such request. 

  

	5.	WE CAN TRANSFER THIS PLAIN ENGLISH WARRANT AGREEMENT. 

 Subject to the terms and conditions contained in Section 7, We (or any successor transferee) may transfer in whole or in part this Warrant Agreement and all its rights. You will record the transfer
on Your books when You receive Our Notice of Transfer in the form attached hereto as Exhibit III, and Our payment of all transfer taxes and other governmental charges involved in such transfer. 

 

	6.	REPRESENTATIONS, WARRANTIES, AND COVENANTS FROM YOU. 

  

	•	 	 Reservation of Warrant Stock. The Warrant Stock issuable upon exercise of Our rights under this Warrant Agreement will be duly and validly
reserved and when issued in accordance with the provisions of this Warrant Agreement will be validly issued, fully paid and non-assessable, and will be free of any taxes, liens, charges or encumbrances of any nature whatsoever (other than any liens,
charges and encumbrances created by Us or by this Warrant Agreement); provided, however, that the Warrant Stock issuable pursuant to this Warrant Agreement may be subject to restrictions on transfer under state and/or Federal securities laws. Upon
Our exercise, You will issue to Us certificates for shares of Warrant Stock without charging Us any tax, or other cost incurred by You in connection with such exercise and the related issuance of shares of Warrant Stock. You will not be required to
pay any tax, which may be payable in respect of any transfer involved and the issuance and delivery of any certificate in a name other than TriplePoint Capital LLC. 

 

	•	 	 Due Authority. Your execution and delivery of this Warrant Agreement and the performance of Your obligations hereunder, including the issuance
to Us of the right to acquire the shares of Warrant Stock, have been duly authorized by all necessary corporate action on Your part and this Warrant Agreement is not inconsistent with Your Certificate of Incorporation or Bylaws, does not contravene
any law or governmental rule, regulation or order applicable to it, do not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument to which You are a party or by which You are

  
 5 

	 	 
bound, and this Warrant Agreement constitutes a legal, valid and binding agreement, enforceable in accordance with its respective terms, subject to laws of general application relating to
bankruptcy, insolvency and the relief of debtors and the rules of law or principles at equity governing specific performance, injunctive relief and other equitable remedies. 

 

	•	 	 Consents and Approvals. No consent or approval of, giving of notice to, registration with, or taking of any other action in respect of any
state, Federal or other governmental authority or agency is required with respect to execution, delivery and Your performance of Your obligations under this Warrant Agreement, except for the filing of any required notices pursuant to Federal and
state securities laws, which filings will be effective by the times required thereby. 

  

	•	 	 Issued Securities. All of Your issued and outstanding shares of Common Stock, Warrant Stock or any other securities have been duly authorized
and validly issued and are fully paid and nonassessable. All outstanding shares of Common Stock and Warrant Stock were issued in full compliance with all Federal and state securities laws. In addition as of the Effective Date:

 Your authorized capital consists of (A) 32,000,000 shares of Common Stock, of which 10,449,795 shares of Common Stock
are issued and outstanding, and (B) 44,401,072 shares of preferred stock, of which 43,542,403 shares are issued and outstanding. 
 You
have reserved 9,178,694 shares of Common Stock for issuance under Your Stock Incentive Plan, under which 4,636,602 options have been granted. Except as otherwise provided in this Warrant Agreement and as noted above, there are no other options,
warrants, conversion privileges or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued shares of Your capital stock or other of Your securities. 
 Except as set forth in Your Investor’s Rights Agreement, a true, correct and complete copy of which has been delivered to Us prior to the issuance of this Warrant, Your stockholders do not have
preemptive rights to purchase new issuances of Your capital stock. 
  

	•	 	 Other Commitments to Register Securities. Except as set forth in this Warrant Agreement and the Investors’ Rights’ Agreement, You are
not, pursuant to the terms of any other agreement currently in existence, under any obligation to register under the 1933 Act any of Your presently outstanding securities or any of Your securities which may hereafter be issued.

  

	•	 	 Exempt Transaction. Subject to the accuracy of Our representations in Section 7 hereof, the issuance of the Warrant Stock upon exercise of
this Warrant Agreement will constitute a transaction exempt from (i) the registration requirements of Section 5 of the 1933 Act, in reliance upon Section 4(2) thereof, and (ii) the qualification requirements of the applicable
state securities laws. 

  

	•	 	 Compliance with Rule 144. We may sell the Warrant Stock issuable hereunder in compliance with Rule 144 promulgated by the Securities and
Exchange Commission. Within ten (10) days of Our request, You agree to furnish Us, a written statement confirming Your compliance with the filing requirements of the Securities and Exchange Commission as set forth in such Rule 44, as may be
amended. 

  

	•	 	 No Impairment. You agree not to, by amendment of Your Certificate of Incorporation or through a reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by You, but shall at all times in
good faith assist in carrying out of all the provisions of this Warrant and in taking all such action as may be necessary or appropriate to protect Our rights under this Warrant against impairment. Notwithstanding the foregoing, You shall not be
deemed to have impaired Our rights with any amendment of Your Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, if such
amendment or transaction affects the rights, privileges, preferences of the securities then issuable upon exercise of this Warrant (the “Shares”) in a manner that is not different from the effect on the outstanding securities of You that
are of the same series and class as the Shares. 

  
 6 

	7.	OUR REPRESENTATIONS AND COVENANTS TO YOU. 

  

	•	 	 Investment Purpose. The right to acquire Warrant Stock or the Warrant Stock issuable upon exercise of Our rights contained herein and the Common
Stock issuable upon conversion will be acquired for investment purposes and not with a view to the sale or distribution of any part thereof, and We have no present intention of selling or engaging in any public distribution of the same in violation
of the 1933 Act. 

  

	•	 	 Private Issue. We understand (i) that this Warrant Agreement, the Warrant Stock issuable upon exercise of this Warrant Agreement and the
Common Stock issuable upon conversion of the Warrant Stock are not registered under the 1933 Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Warrant Agreement will be exempt from the
registration and qualifications requirements thereof, and (ii) that Your reliance on such exemption is predicated on the representations set forth in this Section 7. 

 

	•	 	 Disposition of Our Rights. In no event will We make a disposition of any of Our rights to acquire Warrant Stock or Warrant Stock issuable upon
exercise of such rights or the Common Stock issuable upon conversion of the Warrant Stock unless and until (i) We shall have notified You in writing of the proposed disposition, and (ii) the transferee agrees to be bound in writing to the
applicable terms and conditions of this Warrant Agreement, and (iii) if You request, We shall have furnished You with an opinion of counsel satisfactory to You and Your counsel to the effect that (A) appropriate action necessary for
compliance with the 1933 Act has been taken, or (B) an exemption from the registration requirements of the 1933 Act is available. Notwithstanding the foregoing, the restrictions imposed upon the transferability of any of Our rights to acquire
Warrant Stock or Warrant Stock issuable on the exercise of such rights or the Common Stock issuable upon conversion of the Warrant Stock do not apply to transfers from the beneficial owner of any of the aforementioned securities to its nominee or
from such nominee to its beneficial owner, and shall terminate as to any particular share of Warrant Stock when (1) such security shall have been effectively registered under the 1933 Act and sold by the holder thereof in accordance with such
registration or (2) such security shall have been sold without registration in compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been issued to You at Our request by the staff of the Securities and Exchange Commission
or a ruling shall have been issued to the You at Our request by such Commission stating that no action shall be recommended by such staff or taken by such Commission, as the case may be, if such security is transferred without registration under the
1933 Act in accordance with the conditions set forth in such letter or ruling and such letter or ruling specifies that no subsequent restrictions on transfer are required. Whenever the restrictions imposed hereunder shall terminate, as hereinabove
provided, the holder of a share of Warrant Stock then outstanding as to which such restrictions have terminated shall be entitled to receive from You, without expense to such holder, one or more new certificates for the Warrant or for such shares of
Warrant Stock not bearing any restrictive legend referring to 1933 Act registration or exemption. 

  

	•	 	 Financial Risk. We have such knowledge and experience in financial and business matters and knowledge of Your business affairs and financial
condition as to be capable of evaluating the merits and risks of Our investment, and have the ability to bear the economic risks of Our investment. 

  

	•	 	 Risk of No Registration. We understand that if You do not register with the Securities and Exchange Commission pursuant to Section 12 of
the 1934 Act (the “1934 Act”), or file reports pursuant to Section 15(d), of the 1934 Act, or if a registration statement covering the securities under the 1933 Act is not in effect when We desire to sell (i) the rights to
purchase Warrant Stock pursuant to this Warrant Agreement, or (ii) the Warrant Stock issuable upon exercise of the right to purchase, or (iii) the Common Stock issuable upon conversion of the Warrant Stock, We may be required to hold such
securities for an indefinite period. We also understand that any sale of Our right to purchase Warrant Stock or Warrant Stock or Common Stock issuable upon conversion of the Warrant Stock, which might be made by it in reliance upon Rule 144 under
the 1933 Act may be made only in accordance with the terms and conditions of that Rule. 

  

	•	 	 Accredited Investor. We are an “accredited investor” within the meaning of the Securities and Exchange Rule 501 of Regulation D of the
1933 Act, as presently in effect. 

  
 7 

	8.	NOTICES YOU AGREE TO PROVIDE US. 

 You
agree to give Us at least twenty (20) days prior written notice (or such shorter period of prior notice as You shall provide to the other holders of your Series C Preferred Stock or Common Stock consistent with Your Certificate of
Incorporation) of the following events: 
  

	•	 	 If You Pay a Dividend or distribution declaration upon your stock. 

 

	•	 	 If You offer for subscription pro-rata to the existing shareholders additional stock or other rights. 

 

	•	 	 If You consummate or sign definitive documents providing for a Merger Event. 

 

	•	 	 If You have an IPO. 

  

	•	 	 If You dissolve or liquidate. 

 All notices in this Section must set forth details of the event, how the event adjusts either Our number of shares or Our Exercise Price and the method used for such adjustment. 

Timely Notice. Your failure to timely provide such notice required above shall entitle Us to retain the benefit of the applicable notice period
notwithstanding anything to the contrary contained in any insufficient notice received by Us. 
  

	9.	DOCUMENTS YOU WILL PROVIDE US. 

Upon signing this Agreement You will provide Us with: 
  

	•	 	 Executed originals of this Agreement, and all other documents and instruments that We may reasonably require 

 

	•	 	 Secretary’s certificate of incumbency and authority 

 

	•	 	 Certified copy of resolutions of Your board of directors approving this Agreement 

 

	•	 	 Certified copy of Certificate of Incorporation and By-Laws as amended through the Effective Date 

 

	•	 	 Current Investor’s Rights Agreement 

 So long as this Warrant Agreement is in effect, You shall provide Us with the following: 
  

	•	 	 Within fifteen (15) Business Days after the closing of any equity financing, or extension of an existing round of equity financing, occurring
after the Effective Date, in which You issue preferred stock or other securities You will provide Us with copies of the fully executed equity financing documents, including without limitation the related stock purchase agreement, investors rights
agreement, voting agreement, amended or restated certificates of incorporation, current capitalization table and other related documents. Notwithstanding any term or condition contained in this Warrant Agreement, the Loan Agreement to the contrary,
Your failure to comply with this paragraph shall not constitute an Event of Default unless You have not provided the information requested within ten (10) days of Our request 

 

	•	 	 Promptly upon Our request, after its completion, You shall provide Us with any 409A Valuation Reports or other similar reports prepared for You.

  

	•	 	 You shall submit to Us any other documents and other information that We may reasonably request from time to time and are necessary to implement the
provisions and purposes of this Warrant Agreement. 

  
 8 

	10.	REGISTRATION RIGHTS UNDER THE 1933 ACT. 

Pursuant to that certain First Amendment to the Amended and Restated Investors’ Rights Agreement (the “Amendment”), the shares of Your
Common Stock into which the Warrant Stock is convertible shall have registration rights as set forth in the Amended and Restated Investors’ Rights Agreement, dated as of December 9, 2008 (the “Investors’ Rights Agreement”).
The provisions set forth in Your Investors’ Rights Agreement relating to such registration rights in effect as of the date of this Warrant Agreement may not be amended, modified or waived without Our prior written consent unless such amendment,
modification or waiver affects the rights associated with the shares of common stock into which the Warrant Stock is convertible in the same manner as such amendment, modification, or waiver affects the rights associated with all other shares of the
same series and class of stock as the Warrant Stock. We understand and agree that the shares of Warrant Stock (and the shares of Your Common Stock into which the Warrant Stock is convertible) shall be subject to Section 1.15 of the Investors
Rights Agreement and that by execution of the Amendment, We hereby agree to be bound by the terms thereof. 
  

	11.	OTHER LEGAL PROVISIONS THE PARTIES WILL ABIDE BY. 

 Effective Date. This Warrant Agreement shall be construed and shall be given effect in all respects as if it had been executed and delivered by the Parties on the date hereof. This Warrant
Agreement shall be binding upon any of the successors or assigns of the Parties. 
 Attorney’s Fees. In any litigation, arbitration
or court proceeding between the Parties relating to this Warrant Agreement, the prevailing party shall be entitled to attorneys’ fees and expenses and all costs of proceedings incurred in enforcing this Warrant Agreement. 

Governing Law. This Warrant Agreement shall be governed by and construed for all purposes under and in accordance with the laws of the State of
California without giving effect to that body of law pertaining to conflicts of laws. 
 Consent to Jurisdiction and Venue. All judicial
proceedings arising in or under or related to this Warrant Agreement may be brought in any state or federal court of competent jurisdiction located in the State of California. By execution and delivery of this agreement, each party hereto generally
and unconditionally: (a) consents to personal jurisdiction in San Mateo County, State of California; (b) waives any objection as to jurisdiction or venue in San Mateo County, State of California; (c) agrees not to assert any defense
based on lack of jurisdiction or venue in the aforesaid courts; and (d) irrevocably agrees to be bound by any judgment rendered thereby in connection with this Plain English Warrant Agreement. Service of process on any party hereto in any
action arising out of or relating to this agreement shall be effective if given in accordance with the requirements for notice set forth in this Section, and shall be deemed effective and received as set forth therein. Nothing herein shall affect
the right to serve process in any other manner permitted by law or shall limit the right of either party to bring proceedings in the courts of any other jurisdiction. 
 Mutual Waiver of Jury Trial; Judicial Reference. Because disputes arising in connection with complex financial transactions are most quickly and economically resolved by an experienced and expert
person and The Parties wish applicable state and federal laws to apply (rather than arbitration rules), The Parties desire that their disputes be resolved by a judge applying such applicable laws. EACH OF THE PARTIES SPECIFICALLY WAIVES ANY RIGHT
THEY MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM (COLLECTIVELY, “CLAIMS”) ASSERTED BY YOU AGAINST US OR OUR ASSIGNEE OR BY US OR OUR ASSIGNEE AGAINST YOU.
IN THE EVENT THAT THE FOREGOING JURY TRIAL WAIVER IS NOT ENFORCEABLE, ALL CLAIMS, INCLUDING ANY AND ALL QUESTIONS OF LAW OR FACT RELATING THERETO, SHALL, AT THE WRITTEN REQUEST OF ANY PARTY, BE DETERMINED BY JUDICIAL REFERENCE PURSUANT TO THE
CALIFORNIA CODE OF CIVIL PROCEDURE (“REFERENCE”). THE PARTIES SHALL SELECT A SINGLE NEUTRAL REFEREE, WHO SHALL BE A RETIRED STATE OR FEDERAL JUDGE. IN THE EVENT THAT THE PARTIES CANNOT AGREE UPON A REFEREE, THE REFEREE SHALL BE APPOINTED
BY THE COURT. THE REFEREE SHALL REPORT A STATEMENT OF DECISION TO THE COURT. NOTHING IN THIS SECTION SHALL LIMIT THE RIGHT OF ANY PARTY AT ANY TIME TO EXERCISE LAWFUL SELF-HELP REMEDIES, FORECLOSE AGAINST COLLATERAL OR OBTAIN

  
 9 

 
PROVISIONAL REMEDIES. THE PARTIES SHALL BEAR THE FEES AND EXPENSES OF THE REFEREE EQUALLY UNLESS THE REFEREE ORDERS OTHERWISE. THE REFEREE SHALL ALSO DETERMINE ALL ISSUES RELATING TO THE
APPLICABILITY, INTERPRETATION, AND ENFORCEABILITY OF THIS SECTION. THE PARTIES ACKNOWLEDGE THAT THE CLAIMS WILL NOT BE ADJUDICATED BY A JURY. This waiver extends to all such Claims, including Claims that involve Persons other than You and Us; Claims
that arise out of or are in any way connected to the relationship between You and Us; and any Claims for damages, breach of contract, specific performance, or any equitable or legal relief of any kind, arising out of this Warrant Agreement.

 Counterparts. This Warrant Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all
of which together shall constitute one and the same instrument. 
 Notices. Any notice required or permitted under this Warrant Agreement
shall be given in writing and shall be deemed effectively given upon the earlier of (1) actual receipt or 3 days after mailing if mailed postage prepaid by regular or airmail to Us or You or (2) one day after it is sent by overnight mail
via nationally recognized courier or (3) on the same day as sent via confirmed facsimile transmission, provided that the original is sent by personal delivery or mail by the sending party. 

Remedies. In the event of any default hereunder, the non-defaulting party may proceed to protect and enforce its rights either by suit in equity
and/or by action at law, including but not limited to an action for damages as a result of any such default, and/or an action for specific performance for any default where such party will not have an adequate remedy at law and where damages will
not be readily ascertainable. Each party expressly acknowledges and agrees that there is no adequate remedy at law for any breach of this Warrant Agreement and that in the event of any breach of this Agreement, the injured party shall be entitled to
specific performance of any or all provisions hereof or an injunction prohibiting the other party from continuing to commit any such breach of this Agreement. 
 Survival. The representations, warranties, covenants, and conditions of the Parties contained herein or made pursuant to this Warrant Agreement shall survive the execution and delivery of this
Warrant Agreement. 
 Severability. In the event any one or more of the provisions of this Warrant Agreement shall for any reason be held
invalid, illegal or unenforceable, the remaining provisions of this Warrant Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, legal and enforceable provision, which
comes closest to the intention of the parties underlying the invalid, illegal or unenforceable provision. 
 Entire Agreement. This
Warrant Agreement constitutes the entire agreement between the Parties pertaining to the subject matter contained in it and supersedes all prior and contemporaneous agreements, representations and undertakings of the Parties, whether oral or
written, with respect to such subject matter. 
 Amendments. Any provision of this Warrant Agreement may only be amended by a written
instrument signed by the Parties. 
 Lost Warrants or Stock Certificates. You covenant to Us that, upon receipt of evidence reasonably
satisfactory to Us of the loss, theft, destruction or mutilation of this Warrant Agreement or any stock certificate and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to You, or in the case
of any such mutilation upon surrender and cancellation of such Warrant Agreement or stock certificate, You will make and deliver a new Warrant Agreement or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant
Agreement or stock certificate. 
 Rights as Stockholders. We shall not, as a party to this Warrant Agreement, be entitled to vote or
receive dividends or be deemed the holder of Series C-2 Preferred Stock or any of Your other securities which may at any time be issuable upon the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon Us
any of the rights of one of Your stockholders or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive dividends or subscription rights or otherwise

  
 10 

 
until this Warrant Agreement is exercised and the shares purchasable upon the exercise hereof shall have become deliverable, as provided herein. 

Facsimile Signatures. This Warrant Agreement may be executed and delivered by facsimile and upon such delivery the facsimile signature will be
deemed to have the same effect as if the original signature had been delivered to the other party. 
 (Signature Page to
Follow) 

  
 11 

 IN WITNESS WHEREOF, each of the Parties have caused this Warrant Agreement to be executed by its
officers who arc duly authorized as of the Effective Date. 
  

			
	You:	 	CHEGG, INC.
		
	Signature:	 	 /s/ Osman Rashid

		
	Print Name:	 	 Osman Rashid

		
	Title:	 	 CEO

		
	Us:	 	TRIPLEPOINT CAPITAL LLC
		
	Signature:	 	 /s/ Sajal Srivastava

		
	Print Name:	 	 Sajal Srivastava

		
	Title:	 	 Chief Operating Officer

 [SIGNATURE PAGE TO WARRANT AGREEMENT 0592-W-01] 

  
 12 

 EXHIBIT I 
 NOTICE OF EXERCISE 
  

	To:	[                    ] 

 

	1.	We hereby elect to purchase [                    ] shares of
the Series [        ] Preferred Stock of [            ], pursuant to the terms of the Plain English Warrant Agreement dated the
[            ] day of [                    ],[200  ] (the
“Plain English Warrant Agreement”) between You and Us, We hereby tender here payment of the purchase price for such shares in full, together with all applicable transfer taxes, if any. 

 

	2.	Method of Exercise (Please initial the applicable blank) 

  

	 	a.	             The undersigned elects to exercise the Plain English Warrant Agreement by means of a
cash payment, and gives You full payment for the purchase price of the shares being purchased, together with all applicable transfer taxes, if any. 

  

	 	b.	             The undersigned elects to exercise the Plain English Warrant Agreement by means of the
Net Issuance Exercise method of Section 3 of the Plain English Warrant Agreement. 

  

	3.	In exercising Our rights to purchase the Series [        ] Preferred Stock of
[            ], We hereby confirm and acknowledge the investment representations, warranties and covenants made in Section 7 of the Plain English Warrant Agreement.

 Please issue a certificate or certificates representing these purchased shares of Series
[        ] Preferred Stock in Our name or in such other name as is specified below. 
  

			
	  

	(Name)
	
	  

	(Address)
		
	US:	 	TRIPLEPOINT CAPITAL LLC
		
	By:	 	  

		
	Title:	 	  

		
	Date:	 	  

  
 13 

 EXHIBIT II 
 ACKNOWLEDGMENT OF EXERCISE 

[                    ], hereby acknowledges
receipt of the “Notice of Exercise” from TRIPLEPOINT CAPITAL LLC, to purchase [            ] shares of the Series [        ]
Preferred Stock of [            ], pursuant to the terms of the Plain English Warrant Agreement, and further acknowledges that
[            ] shares remain subject to purchase under the terms of the Plain English Warrant Agreement. 

 

					
	 YOU:
	 	  

			
		 	By:	 	  

			
		 	Title:	 	  

			
		 	Date:	 	  

  
 14 

 EXHIBIT III 
 TRANSFER NOTICE 
 FOR VALUE RECEIVED, the foregoing Plain English Warrant Agreement
and all rights evidenced thereby are hereby transferred and assigned to 
  

					
	  
	 		 	
	(Please Print)	 		 	

  

					
	 Whose address is
	 	  
	 	
		
	  
	 	

  

							
	Dated:	 	  
	 		 	
				
	Holder’s Signature:	 	  
	 		 	
				
	Holder’s Address:	 	  
	 		 	
				
	Transferee’s Signature:	 	  
	 		 	
				
	Transferee’s Address:	 	  
	 		 	
				
	Signature Guaranteed:	 	  
	 		 	

 NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the Plain
English Warrant Agreement, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Plain
English Warrant Agreement. 

  
 15 

 

 
 PLAIN ENGLISH INTELLECTUAL PROPERTY SECURITY AGREEMENT 

This is a Plain English Intellectual Property Security Agreement dated April 24, 2009 by and between TriplePoint Capital LLC, a Delaware
company and Chegg, Inc., a Delaware corporation. 
 The words “We”, “Us”, or “Our”, refer to the grantee, which is
TriplePoint Capital LLC. The words “You” or “Your” refers to the grantor, which is Chegg, Inc. and not any individual. The words “the Parties” refers to both TriplePoint Capital LLC and Chegg, Inc. 

The Parties have entered into a Plain English Revolving Loan and Security Agreement dated April 24, 2009 (together with amendments, supplements,
extensions and exhibits, collectively the “Loan Agreement”). Pursuant to the Loan Agreement, You have granted to Us a lien on and a security interest in all the present and future rights, title, and interest that You may now have or
hereafter acquire in all Patents, Trademarks, Copyrights, and applications for Patents, Trademarks and Copyrights. 
 In consideration for the
mutual covenants and agreements contained in the Loan Agreement and this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the Parties agree as follows: 

 

	1.	GRANT OF SECURITY INTEREST OF PATENTS 

You grant to Us a lien upon and continuing security interest in all of Your right, title, and interest in, to and under all of the following (all of the
following items of property collectively will be referred to as the “Intellectual Property Collateral”), whether now existing or hereafter arising or acquired: 

 

	 	•	 	 all Patents, Patent Licenses, and Patent applications, including specifically those listed on the attached Schedule A, together with any
reissues, divisions, continuations, renewals, extensions and continuations thereof; 

  

	 	•	 	 all Trademarks, Trademark Licenses, and trademark applications, including specifically those listed on the attached Schedule B together with any
renewals thereof; 

  

	 	•	 	 all Copyrights, Copyright Licenses, and applications for Copyrights, including specifically those listed on the attached Schedule C;

  

	 	•	 	 the right to sue for past, present and future infringements of the foregoing and all rights corresponding thereto throughout the world and all
re-issues, divisions continuations, renewals, extensions and continuations-in-part thereof; and 

  

	 	•	 	 all Proceeds. 

 You
represent and warrant to Us that Schedules A, B, and C attached hereto set forth any and all intellectual property rights in connection to which You have registered or filed an application with either the United States Patent and Trademark Office or
the United States Copyright Office, as applicable. 
  

	2.	LOAN AGREEMENT 

 This security interest is
granted to secure the Secured Obligations, under the Loan Agreement. All the capitalized terms used but not otherwise defined are used in this Agreement with the same meaning as defined in the Loan Agreement. 

	3.	OUR RIGHT TO SUE 

 From and after an Event
of Default, subject to the terms of the Loan Agreement, We shall have the right, but shall in no way be obligated, to bring suit in Our own name to enforce Your rights in the Intellectual Property Collateral. If We commence any such suit, You shall,
at the Our request, do all lawful acts and execute and deliver all proper documents or information that may be necessary or desirable to aid Us in such enforcement. You shall promptly, upon demand, reimburse and indemnify Us for all of Our costs and
expenses, including reasonable attorney’s fees, related to Our exercise of the above mentioned rights. 
  

	4.	FURTHER ASSURANCES 

 You will from time to
time execute, deliver and file, alone or with Us, any security agreements, or other documents to perfect and give priority to Our lien on the Intellectual Property Collateral. You will from time to time obtain any instruments or documents as We may
request, and take all further action that may be reasonably necessary or desirable, or that We may reasonably request, to carry out more effectively the provisions and purposes of this Agreement or any other related agreements or to confirm,
perfect, preserve and protect the liens granted to Us. 
  

	5.	MODIFICATION 

 This Agreement can only be
altered, amended or modified in a writing signed by the Parties. Notwithstanding the foregoing however, You hereby irrevocably appoints Us (and any of Our designated officers, agents or employees) as Your true and lawful attorney to modify, in Our
sole discretion, this Agreement without first obtaining Your approval of or signature to such modification by amending Schedules A, B, and C to this Agreement, as appropriate, to include reference to any right, title or interest in any Intellectual
Property Collateral acquired by You before or after the execution hereof or to delete any reference to any right, title or interest in any Intellectual Property Collateral in which You no longer have or claim to have any right, title or interest.
The appointment of Us as Your attorney in fact, and each and every one of Our rights and powers, being coupled with an interest, is irrevocable until all of the Secured Obligations have been fully repaid and performed and Our obligation to provide
credit extensions to You is terminated. 
  

	6.	BINDING EFFECT; REMEDIES NOT EXCLUSIVE 

This Agreement shall be binding upon You and Your respective successors and assigns, and shall inure to the benefit of Us, and Our nominees and assigns.

 Our rights and remedies with respect to the security interest granted hereby are in addition to those set forth in the Loan Agreement and the
other Loan Documents, and those which are now or hereafter available to Us as a matter of law or equity. Each of Our rights, powers and remedies provided for herein or in the Loan Agreement or any of the Loan Documents, or now or hereafter existing
at law or in equity shall be cumulative and concurrent and shall be in addition to every right, power or remedy provided for herein and the exercise by Us of any one or more of the rights, powers or remedies provided for in this Intellectual
Property Security Agreement, the Loan Agreement or any of the other Loan Documents, or now or hereafter existing at law or in equity, shall not preclude the simultaneous or later exercise by any person, including Us, of any or all other rights,
powers or remedies. 
  

	7.	GOVERNING LAW; COUNTERPARTS 

 This
Agreement shall be deemed made and accepted in and shall be governed by and construed in accordance with the laws of the State of California, and (where applicable) the laws of the United States of America. 

This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall constitute the same
instrument. 
 (Signature Page to Follow) 

  
 2 

 IN WITNESS WHEREOF, You have duly executed this Agreement as of the date first set forth above.

  

			
	You:	 	CHEGG, INC.
		
	Signature:	 	 /s/ Osman Rashid

		
	Print Name:	 	 Osman Rashid

		
	Title:	 	 CEO

 [SIGNATURE PACE TO PLAIN ENGLISH INTELLECTUAL PROPERTY SECURITY AGREEMENT] 

  
 3 

 SCHEDULE A 
 To Plain English Intellectual Property Security Agreement 
 Between Chegg,
Inc. As You (Grantor) 
 and Triplepoint Capital LLC, as Us (Grantee) 

PATENTS AND PATENT APPLICATIONS 
 PATENTS 
  

					
	Patent Name	 	Status and Date Issued	 	Patent Number
			
	 n/a
	 		 	

 PATENT APPLICATIONS 

 

					
	Patent Name	 	Status & Date Filed	 	Application Number
			
	 n/a
	 		 	

  
 4 

 SCHEDULE B 
 To Plain English Intellectual Property Security Agreement Between Chegg, Inc., as You (Grantor) and TriplePoint Capital LLC, as Us (Grantee) 

TRADEMARKS AND TRADEMARK APPLICATIONS 
 TRADEMARKS 
  

							
	Name	  	Date Filed or
Issued	  	Serial Number	  	Status
	 #1 IN TEXTBOOK RENTALS
	  	06-10-2008	  	3,447,212	  	Declaration of Continued Use due by 06-10-2014.
	 CHEGG
	  	01-02-2007	  	3,191,844	  	Declaration of Continued Use due by 01-02-2013.

 TRADEMARK APPLICATIONS 

 

							
	Name	  	Date Filed	  	Serial Number	  	Status
	 DON’T BUY TEXTBOOKS
	  	03-06-2008	  	77/415,587	  	Published 07-22-2008
	 DON’T BUY TEXTBOOKS LOGO DESIGN
	  	03-19-2008	  	77/426,745	  	Published 07-22-2008

  
 5 

 SCHEDULE C 
 TO INTELLECTUAL PROPERTY SECURITY AGREEMENT 
 Between Chegg, Inc. as You
(Grantor) 
 And Triplepoint Capital LLC, as Us (Grantee) 

COPYRIGHT REGISTRATIONS 
  

							
	Registration Number	  	Title	  	Registration Date	  	V&A No.
				
	 n/a
	  		  		  	

 APPLICATIONS FOR COPYRIGHT REGISTRATIONS 

 

					
	Title	  	Date Filed	  	V&A No.
			
	 n/a
	  		  	

  
 6EX-4.06

 Exhibit 4.06 
 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS
RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR
(iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 9 OF THIS WARRANT. 
 CHEGG. INC. 

WARRANT TO PURCHASE PREFERRED STOCK 
 For value received and subject to the provisions set forth in this warrant (this “Warrant”), TRIPLEPOINT CAPITAL LLC and its assigns (the “Holder”)
are entitled to purchase from CHEGG, INC., a Delaware corporation (the “Company”): 
  

			
	Warrant Coverage:	  	$787,250 (i.e., 7.8725% of $10,000,000) upon your execution of this Warrant and up to a maximum of $387,750 additional warrant coverage, determined as 3.8775% of any Advance (as
defined in the Loan Agreement (as defined below))
		
	Shares of Preferred Stock:	  	242,231 shares of Series C-2 Preferred Stock on the date hereof and up to an additional 119,308 shares based upon Advances (as defined in the Loan Agreement (as defined below))
(subject to adjustment in accordance with the terms of this Warrant)
		
	Exercise Price:	  	$3.25 per share (subject to adjustment in accordance with the terms of this Warrant)
		
	Term of Warrant:	  	The later of (i) 10 years from the Warrant Date and (ii) five years from the date of the Company’s initial public offering.
		
	Warrant Date:	  	October 13, 2009
		
	Warrant Number	  	0592-W-02

 The number of Shares for which this Warrant is exercisable and the Exercise Price may be adjusted as specified in
Section 5. 
 1. Definitions. As used herein, capitalized terms not otherwise defined herein shall have the
meanings set forth in the introductory paragraph of this Warrant or the following meanings: 

  

					
		  		  	WARRANT (TriplePoint)

 (a) “Applicable Stock” means (i)(A) if the Exercise Price is the
Series C-2 Price, then the Company’s presently authorized Series C-2 Preferred Stock, or (B) if the Exercise Price is the Future Round Price, then the series of convertible preferred stock sold in such Qualified Offering, (ii) after
the conversion of all of the outstanding shares of such series of preferred stock into Common Stock, either automatically or by vote of the requisite holders thereof, the Company’s Common Stock, and (iii) upon any conversion, exchange,
reclassification or change, any security into which the securities described in clauses (i) or (ii) of this definition may be converted, exchanged, reclassified or otherwise changed. 

(b) “Common Stock” means the common stock of the Company. 

(c) “Exercise Price” means the exercise price per share of Applicable Stock and shall equal the lesser of
(i) the Series C-2 Price or (ii) the lowest Future Round Price if the Company completes an equity financing after the Warrant Date and prior to the exercise of any portion of this Warrant. 

(d) “Future Round Price” means the price per share of the equity securities sold in any Company Qualified
Financing after the Warrant Date. 
 (e) “Holder” means the initial holder of this Warrant set forth in
the first paragraph of this Warrant and any other person or entity which becomes a holder of this Warrant pursuant to the terms of this Warrant. 
 (f) “Loan Agreement” means that certain Loan and Security Agreement, dated as of the date hereof, entered into by and between the Company and Holder and the other parties signatory
thereto, as amended, restated or otherwise modified from time to time. 
 (g) “Number of Shares” means
that number of shares for which this Warrant is exercisable and shall equal the Warrant Coverage divided by the Exercise Price, if such Shares are Preferred Stock, or the Common Stock Equivalent thereof, if such Shares have been converted to Common
Stock. 
 (h) “Qualified Financing” means the sale after the date hereof and prior to the Company’s
initial public offering, of a series of convertible preferred stock of the Company to purchasers resulting in gross proceeds to the Company of not less than $2,000,000 (excluding any bridge debt financing except to the extent actually converted to
equity in the Company). 
 (i) “Series C-2 Price” means $3.25 per share. 

(j) “Shares” means the shares of Applicable Stock of Company issuable upon exercise of this Warrant. 

(k) “Warrant Coverage” initially means $787,250; provided however, that upon any Advance under the Loan
Agreement, Warrant Coverage shall be increased by the product of (i) the amount of such Advance times 3.8775%) up to a maximum warrant coverage of $1,175,000. 

  

					
		  	-2-	  	WARRANT (TriplePoint)

 (l) “Warrant Date” means the date of this Warrant specified in the
introductory paragraph of this Warrant. 
 2. Term; Excerise Upon a Merger Event. 

(a) Term. The right to purchase Applicable Stock upon exercise hereof is exercisable at any time and from time to time from the
Warrant Date until the later of (i) tenth anniversary of the Warrant Date and (ii) five years from the effective date of the Company’s initial public offering. 
 (b) Exercise Upon a Merger Event. Notwithstanding Section 5 herein, Holder’s right to purchase the Applicable Stock shall be automatically and fully exercised via the net issuance method
described below (without surrender of the Warrant) upon the occurrence of a Merger Event (as such term is defined below), with a person that is not an affiliate, in which the Company common stock is exchanged for one or more of (i) cash or
(ii) if the Company is acquired by a publicly traded acquirer and the total per share consideration of the publicly traded Shares (or other publicly traded securities issuable upon exercise of this Warrant) is equal to or greater than three
(3) times the aggregate Exercise Price (as adjusted). No less than ten (10) business days prior to any Merger Event, the Company shall provide Holder with written notice of the proposed Merger Event together with a copy of the executed
merger agreement, or other definitive documentation (and all schedules and exhibits thereto) and information concerning the Company expected capitalization immediately prior to the Merger Event. Upon consummation of the Merger Event, the Company
shall promptly provide the Holder with (a) a copy of any modifications or amendments to the executed merger agreement, (b) any other documents in connection therewith, (c) updated information, if any, concerning Company capitalization
immediately prior to the Merger Event, and, (d) upon request by the Holder, any other information reasonably necessary to an informed evaluation of Holder’s rights under this Warrant. In such Merger Event, if the consideration to be
received by the Company does not consist of cash or publicly traded stock that is traded on a recognized public exchange or the publicly traded stock is less than three (3) times the aggregate Exercise Price and Holder has not elected to
exercise its rights under this Warrant, then the Company may, at Company’s sole discretion, pay Holder a sum equal to three (3) times the Exercise Price for each share exercisable under this Warrant in exchange for the cancellation of this
Warrant upon the consummation of the Merger Event. 
 (c) Fair Market Value. The Parties agree that this Warrant to
purchase the Applicable Stock has a fair market value equal to $100 and that $100 of the issue price of the investment will be allocable to the Warrant and the balance shall be allocable to the Loan Agreement for income tax purposes and the original
issue discount on the Loan Agreement shall be considered to be zero. 
 3. Payment and Exercise. 

(a) Methods of Exercise. The purchase right represented by this Warrant may be exercised by the Holder, in whole or in part and
from time to time, at the election of the Holder, by (a) the surrender of this Warrant (with the notice of exercise substantially in the form attached hereto as Exhibit A duly completed and executed) at the principal office of the

  

					
		  	-3-	  	WARRANT (TriplePoint)

 
Company and by the payment to the Company, by check, or by wire transfer to an account designated by the Company of an amount equal to the then applicable Exercise Price multiplied by the number
of Shares then being purchased (the “Aggregate Purchase Price”); (b) if in connection with a registered public offering of the Company’s securities, the surrender of this Warrant (with the notice of exercise form
attached hereto as Exhibit B duly completed and executed) at the principal office of the Company together with notice of arrangements reasonably satisfactory to the Company for payment to the Company from the proceeds of the sale of shares to be
sold by the Holder in such public offering of the Aggregate Purchase Price; or (c) exercise of the “net issuance” right provided for in Section 3(b) hereof. Following the receipt of a notice of exercise, the Company will promptly
execute the acknowledgement of exercise substantially in the form attached hereto as Exhibit C indicating the number of shares which will be available to the Holder for future purchases, if any. The person or persons in whose name(s) any
certificate(s) representing Shares of Applicable Stock shall be issuable upon exercise of this Warrant shall be deemed to have become the holder(s) of record of, and shall be treated for all purposes as the record holder(s) of, the Shares
represented thereby (and such Shares shall be deemed to have been issued) immediately prior to the close of business on the date or dates upon which this Warrant is exercised. In the event of any exercise of the rights represented by this Warrant,
certificates for the Shares so purchased shall be delivered to the Holder as soon as possible and in any event within twenty-one (21) days after such exercise and, unless this Warrant has been fully exercised or expired, a new Warrant
representing the portion of the Shares, if any, with respect to which this Warrant shall not then have been exercised shall also be issued to the Holder as soon as possible and in any event within such thirty-day period; provided, however, that at
such time as the Company is subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, if requested by the Holder, the Company shall cause its transfer agent to deliver the certificate representing Shares issued upon
exercise of this Warrant to a broker or other person (as directed by the Holder exercising this Warrant) within the time period required to settle any trade made by the Holder after exercise of this Warrant. 

(b) Right to Convert Warrant into Stock: Net Issuance. 
 (i) Net Issuance Right. In addition to and without limiting the rights of the Holder under the terms of this Warrant, the Holder shall have the right to convert this Warrant or any portion thereof
(the “Net Issuance Right”) into shares of Applicable Stock as provided in this Section 3(b) at any time or from time to time during the term of this Warrant. Upon exercise of the Net Issuance Right with respect to a
particular number of shares subject to this Warrant (the “Converted Warrant Shares”), the Company shall deliver to the Holder (without payment by the Holder of any exercise price or any cash or other consideration) that
number of shares of fully paid and nonassessable Applicable Stock as is determined according to the following formula: 
  

							
	X =	 	 A - B
	  	
		 	Y	  	

  

							
			
	Where:	  	X =	  	the number of shares of Applicable Stock that shall be issued to Holder
			
		  	Y =	  	the fair market value of one share of Applicable Stock

  

					
		  	-4-	  	WARRANT (TriplePoint)

							
			
		  	A =	  	the aggregate fair market value of the specified number of Converted Warrant Shares (i.e., the number of Converted Warrant Shares multiplied by the fair market value of
one Converted Warrant Share)
			
		  	B =	  	the aggregate Exercise Price of the specified number of Converted Warrant Shares immediately prior to the exercise of the Net Issuance Right (i.e., the number of
Converted Warrant Shares multiplied by the Exercise Price)

 No fractional shares shall be issuable upon exercise of the Net Issuance Right, and, if the number of shares to be issued
determined in accordance with the foregoing formula is other than a whole number, the Company shall pay to the Holder an amount in cash equal to the fair market value of the resulting fractional share on the Conversion Date (as hereinafter defined).
For purposes of Section 11 of this Warrant, shares issued pursuant to the Net Issuance Right shall be treated as if they were issued upon the exercise of this Warrant. 
 (ii) Exercise of Net Issuance Right. The Net Issuance Right may be exercised by the Holder by the surrender of this Warrant at the principal office of the Company together with a written statement
(which may be in the form of Exhibit A or Exhibit B hereto) specifying that the Holder thereby intends to exercise the Net Issuance Right and indicating the number of shares subject to this Warrant which are being surrendered (referred to in
Section 3(b)(i) hereof as the Converted Warrant Shares) in exercise of the Net Issuance Right. Such conversion shall be effective upon receipt by the Company of this Warrant together with the aforesaid written statement, or on such later date
as is specified therein (the “Conversion Date”), and, at the election of the Holder, may be made contingent upon the closing of the sale of the Company’s Common Stock to the public in a public offering (a
“Public Offering”) pursuant to a Registration Statement under the Securities Act of 1933, amended (the “Act”). Certificates for the shares issuable upon exercise of the Net Issuance Right and, if
applicable, a new warrant evidencing the balance of the shares remaining subject to this Warrant, shall be issued as of the Conversion Date and shall be delivered to the Holder within thirty (30) days following the Conversion Date. 

(iii) Determination of Fair Market Value. For purposes of this Section 3(b), “fair market value” of a share of
Applicable Stock (which shall be Common Stock if the Applicable Stock has been converted into Common Stock) as of a particular date (the “Determination Date”) shall mean: 

(1) If the Net Issuance Right is exercised in connection with and contingent upon a Public Offering, and if the Company’s
Registration Statement relating to such Public Offering (“Registration Statement’) has been declared effective by the Securities and Exchange Commission, then the initial “price to the public” specified in the final
prospectus with respect to such offering. 
 (2) If the Net Issuance Right is not exercised in connection with and contingent
upon a Public Offering, then as follows: 

  

					
		  	-5-	  	WARRANT (TriplePoint)

 (A) If traded on a securities exchange, then the fair market value shall be the average of
the closing prices of the Common Stock on such exchange over the five trading days immediately prior to the Determination Date; 
 (B) If traded on the Nasdaq Stock Market or other over-the-counter system, then the fair market value shall be the average of the closing bid and ask prices of the Common Stock over the five trading days
immediately prior to the Determination Date; and 
 (C) If there is no public market, then fair market value (the highest price
per share which Company could obtain from a willing buyer (not a current employee or director) for shares of Common Stock sold, from authorized but unissued shares) shall be determined in good faith by the Company’s Board of Directors unless
the Company shall become subject to a merger, acquisition or other consolidation pursuant to which the Company is not the surviving party, in which case the fair market value of Common Stock shall be deemed to be the value received by the holders of
the Common Stock pursuant to such merger or acquisition or other consolidation. 
 In making a determination under clauses (A) or
(B) above, if on the Determination Date, five trading days have not passed since the Company’s initial Public Offering then the fair market value of the Common Stock shall be the average closing prices or closing bid and ask prices, as
applicable, for the shorter period beginning on and including the date of the initial Public Offering and ending on the trading day prior to the Determination Date (or if such period includes only one trading day the closing price or closing bid and
ask price, as applicable, for such trading day). If closing prices or closing bid and ask prices are no longer reported by a securities exchange or other trading system, the closing price or closing bid and ask price shall be that which is reported
by such securities exchange or other trading system at 4:00 p.m. New York City time on the applicable trading day. 
 (c)
Partial Exercise. If Holder elects to exercise part of this Warrant, Company will promptly issue to Holder an amended Warrant stating the remaining number of shares that are available. All other terms and conditions of that amended Warrant
shall be identical to those contained in this Warrant. 
 (d) Exercise Prior to Expiration. To the extent this Warrant is
not previously exercised as to all of the Shares subject hereto, and if the fair market value of one share of the Applicable Stock is greater than the Exercise Price then in effect, this Warrant shall be deemed automatically exercised pursuant to
Section 3(b) (even if not surrendered) immediately before its expiration, including but not limited to expiration pursuant to Section 2. For purposes of such automatic exercise, the fair market value of one share of the Applicable Stock
upon such expiration shall be determined pursuant to Section 3(b)(iii). To the extent this Warrant or any portion thereof is deemed automatically exercised pursuant to this Section 3(c), the Company agrees to promptly notify the Holder of
the number of Shares, if any, the Holder is to receive by reason of such automatic exercise. 
 4. Stock Fully Paid;
Reservation of Shares. All Shares that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance pursuant to the terms 

  

					
		  	-6-	  	WARRANT (TriplePoint)

 
and conditions herein, be fully paid and nonassessable, and free from all preemptive rights and taxes, liens and charges with respect to the issuance thereof. During the period within which the
rights represented by this Warrant may be exercised, the Company will at all times have authorized, and reserved for the purpose of the issue upon exercise of the purchase rights evidenced by this Warrant, a sufficient number of shares of its
Applicable Stock to provide for the exercise of the rights represented by this Warrant and, while the Applicable Stock is convertible preferred stock, a sufficient number of shares of its Common Stock to provide for the conversion of the Applicable
Stock into Common Stock. Upon Holder exercise, the Company will issue to Holder certificates for the Shares without charging Holder any tax, or other cost incurred by the Company in connection with such exercise and the related issuance of Shares.

 5. Adjustment of Exercise Price and Number of Shares. The number and kind of securities purchasable upon the
exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time upon the occurrence of certain events, as follows: 
 (a) Reclassification or Merger. In case of any reclassification or change of securities of the class issuable upon exercise of this Warrant (other than a change in par value, or from par value to
no par value, or from no par value to par value, or as a result of a subdivision or combination), or (i) in case of any reorganization or merger of the Company with or into another entity (other than a merger with another entity in which the
Company is the acquiring and the surviving entity and which does not result in any reclassification or change of outstanding securities issuable upon exercise of this Warrant), or (ii) in case of any sale of all or substantially all of the
assets of the Company, or (iii) if the Company shall sell or convey, or grant an exclusive license with respect to, all or substantially all of the Company’s assets to another person, or (iv) their occurs any transaction or series of
related transactions that results in the transfer of 50% or more of the outstanding voting power of the capital stock of the Company (each of the foregoing events (i) through (iv) are referred to as a “Merger
Event”), the Company, or such successor or purchasing corporation, as the case may be, shall duly execute and deliver to the Holder a new Warrant (in form and substance satisfactory to the Holder), or the Company shall make appropriate
provision without the issuance of a new Warrant, so that the Holder shall have the right to receive upon exercise of this Warrant, at a total purchase price not to exceed that payable upon the exercise of the unexercised portion of this Warrant, and
in lieu of the shares of Applicable Stock theretofore issuable upon exercise of this Warrant, the kind and amount of shares of stock, other securities, money and property receivable upon such reclassification, change, or Merger Event by a holder of
the number of shares of Applicable Stock then purchasable under this Warrant. In any such case, appropriate adjustment (as determined in good faith by the Company’s Board of Directors) shall be made in the application of the provisions of this
Warrant with respect to Holder’s rights and interest after the reclassification, change or Merger Event so that the provisions of this Warrant (including adjustments of the Exercise Price and number of Applicable Stock purchasable) shall be
applicable to the greatest extent possible. The provisions of this Section 5(a) shall similarly apply to successive reclassifications, changes, or Merger Events. 
 (b) Subdivision or Combination of Shares. If the Company at any time while this Warrant remains outstanding and unexpired shall subdivide or combine its outstanding shares of Applicable Stock, the
Exercise Price shall be proportionately decreased and the number of Shares issuable hereunder shall be proportionately increased in the case of a subdivision and 

  

					
		  	-7-	  	WARRANT (TriplePoint)

 
the Exercise Price shall be proportionately increased and the number of Shares issuable hereunder shall be proportionately decreased in the case of a combination. 

(c) Stock Dividends and Other Distributions. If the Company at any time while this Warrant is outstanding and unexpired shall pay
a dividend of stock, cash or property to stockholders, or make any other distribution (except any distribution specifically provided for in the above paragraphs) on the Series C-2 Preferred Stock (or such other equity security then underlying the
Warrant), the Company will ensure that Holder will receive the benefit of such dividend or distribution when Holder exercises this Warrant as if Holder had exercised this Warrant when the dividend or distribution was originally made and as if Holder
held Series C-2 Preferred Stock (or such other equity security then underlying the Warrant) on the record date fixed for the determination of the dividend or distribution. 
 (d) Adjustment of Number of Shares. Upon each adjustment in the Exercise Price, the number of Shares of Applicable Stock purchasable hereunder shall be adjusted, to the nearest whole share, to the
product obtained by multiplying the number of Shares purchasable immediately prior to such adjustment in the Exercise Price by a fraction, the numerator of which shall be the Exercise Price immediately prior to such adjustment and the denominator of
which shall be the Exercise Price immediately thereafter. 
 (e) Antidilution Rights. The other antidilution rights
applicable to the Shares of Applicable Stock purchasable hereunder are set forth in the Company’s Certificate of Incorporation, as amended through the Warrant Date, a true and complete copy of which is attached hereto as Exhibit D (the
“Charter”). The Company shall use commercially reasonable efforts to promptly provide the Holder with any restatement, amendment, modification or waiver of the Charter promptly after the same has been made. The Company will
also use commercially reasonable efforts to promptly provide Holder with copies of any notices that the Company sends to holders of the Applicable Stock with respect to any issuance of Company stock or other equity security to occur after the
Warrant Date (other than issuances of stock or equity securities pursuant to customary employee stock plans). Notwithstanding any term or condition contained in this Warrant or the Loan Agreement to the contrary, the Company’s failure to comply
with this paragraph shall not constitute a default unless the Company has not provided the information requested within ten (10) days of such request. 
 6. Notice of Adjustments. Whenever the Exercise Price or the number of Shares purchasable hereunder shall be adjusted pursuant to Section 5 hereof, the Company shall make a certificate
signed by its chief financial officer setting forth, in reasonable detail, the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and the number of Shares
purchasable hereunder after giving effect to such adjustment, and shall cause copies of such certificate to be delivered to the Holder. In addition, whenever the conversion price or conversion ratio of the Applicable Stock shall be adjusted, the
Company shall make a certificate signed by its chief financial officer setting forth, in reasonable detail, the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the conversion
price or ratio of the Applicable Stock after giving effect to such adjustment, and shall cause copies of such certificate to be delivered to the Holder. 

  

					
		  	-8-	  	WARRANT (TriplePoint)

 7. Fractional Shares. No fractional shares of Applicable Stock will be issued
in connection with any exercise hereunder, but in lieu of such fractional shares the Company shall make a cash payment therefor based on the fair market value of the Applicable Stock on the date of exercise as reasonably determined in good faith by
the Company’s Board of Directors. 
 8. Representations of Holder. By its acceptance hereof, Holder
specifically represents to the Company as follows: 
 (a) Holder is aware of the Company’s business affairs and financial
condition, and has acquired information about the Company sufficient to reach an informed and knowledgeable decision to acquire this Warrant. Holder is acquiring this Warrant for its own account for investment purposes only and not with a view to,
or for the resale in connection with, any “distribution” thereof in violation of the Act. 
 (b) Holder understands
that this Warrant has not been registered under the Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Holder’s investment intent as expressed herein. 

(c) Holder further understands that this Warrant must be held indefinitely unless subsequently registered under the Act and qualified
under any applicable state securities laws, or unless exemptions from registration and qualification are otherwise available. Holder is aware of the provisions of Rule 144, promulgated under the Act. 

(d) Holder is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the Act.

 9. Compliance with Act; Disposition of Warrant or Shares of Applicable Stock. 

(a) Compliance with Act . The Holder, by acceptance hereof, agrees that this Warrant, and the shares of Applicable Stock to be
issued upon exercise hereof and any Common Stock issued upon conversion thereof are being acquired for investment and that the Holder will not offer, sell or otherwise dispose of this Warrant, or any shares of Applicable Stock to be issued upon
exercise hereof or any Common Stock issued upon conversion thereof except under circumstances which will not result in a violation of the Act or any applicable state securities laws. Upon exercise of this Warrant, unless the Shares being acquired
are registered under the Act and any applicable state securities laws or an exemption from such registration is available, the Holder shall confirm in writing that the shares of Applicable Stock so purchased (and any shares of Common Stock issued
upon conversion thereof) are being acquired for investment and not with a view toward distribution or resale in violation of the Act and shall confirm such other matters related thereto as may be reasonably requested by the Company. This Warrant and
all shares of Applicable Stock issued upon exercise of this Warrant (unless registered under the Act and any applicable state securities laws) shall be stamped or imprinted with a legend in substantially the following form: 

“THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR
DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL 

  

					
		  	-9-	  	WARRANT (TriplePoint)

 
OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR
(iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 9 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED, DIRECTLY OR INDIRECTLY.” 
 Said legend shall be removed by the Company, upon the request of the Holder, at such time as the restrictions on the transfer of the applicable security shall have terminated. 

(b) Disposition of Warrant or Shares. With respect to any offer, sale or other disposition of this Warrant or any shares of
Applicable Stock acquired pursuant to the exercise of this Warrant prior to registration of such Warrant or shares, the Holder agrees to give written notice to the Company prior thereto, describing briefly the manner thereof, together with a written
opinion of counsel, if requested by the Company, or other evidence, if reasonably satisfactory to the Company, to the effect that such offer, sale or other disposition may be effected without registration or qualification (under the Act as then in
effect or any federal or state securities law then in effect) of this Warrant or such shares of Applicable Stock and indicating whether or not under the Act certificates for this Warrant or such shares of Applicable Stock to be sold or otherwise
disposed of require any restrictive legend as to applicable restrictions on transferability in order to ensure compliance with such law. Upon receiving such written notice and reasonably satisfactory opinion or other evidence, the Company, as
promptly as practicable but no later than fifteen (15) days after receipt of the written notice, shall notify the Holder that the Holder may sell or otherwise dispose of this Warrant or such shares of Applicable Stock, all in accordance with
the terms of the notice delivered to the Company. If a determination has been made pursuant to this Section 9(b) that the opinion of counsel or other evidence is not reasonably satisfactory to the Company, the Company shall so notify the Holder
promptly with details thereof after such determination has been made. Notwithstanding the foregoing, this Warrant or such shares of Applicable Stock may, as to such federal laws, be offered, sold or otherwise disposed of in accordance with Rule 144
or 144A under the Act, provided that the Company shall have been furnished with such information as the Company may reasonably request to provide a reasonable assurance that the provisions of Rule 144 or 144A have been satisfied. Each certificate
representing this Warrant or the shares of Applicable Stock thus transferred (except a transfer pursuant to Rule 144 or 144A) shall bear a legend as to the applicable restrictions on transferability in order to ensure compliance with such laws,
unless in the aforesaid opinion of counsel for the Holder, such legend is not required in order to ensure compliance with such laws. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions.

 (c) Applicability of Restrictions. Neither any restrictions of any legend described in this Warrant nor the
requirements of Section 9(b) above shall apply to any transfer of, or grant of a security interest in, this Warrant (or the Applicable Stock or Common Stock obtainable upon exercise thereof) or any part hereof (i) to a partner of the
Holder if the Holder is a partnership or to a member of or other holder of an interest in the Holder if the Holder is a limited liability company, (ii) to a partnership of which the Holder is a partner or to a limited liability company of which
the Holder is a member or other holder of an interest, or (iii) to any affiliate of the Holder if the Holder is a corporation; provided, however, in any such transfer, if 

  

					
		  	-10-	  	WARRANT (TriplePoint)

 
applicable, the transferee shall on the Company’s request agree in writing to be bound by the terms of this Warrant as if an original holder hereof. 

10. Rights as Stockholders; Information. No Holder, as a holder of this Warrant, shall be entitled to vote or receive
dividends or be deemed the holder of Applicable Stock or any other securities of the Company which may at any time be issuable upon the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as
such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive dividends or subscription rights or otherwise until this
Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein. Notwithstanding the foregoing, the Company will transmit to the Holder such information, documents and reports
as are generally distributed to the holders of any class or series of the securities of the Company concurrently with the distribution thereof to the stockholders. 
 11. Registration Rights. The Company grants registration rights to the Holder for any Applicable Stock of the Company (after its conversion to Common Stock) obtained upon exercise of this
Warrant, comparable to the registration rights granted to the investors in that certain Amended and Restated Investors’ Rights Agreement, dated as of December 9, 2008, as the same may be amended from time to time (the “Investor
Rights Agreement”), with the following exceptions and clarifications: 
 (1) The Holder will not have the
right to demand registration (other than a registration on Form S-3 or any successor form), but can otherwise participate in any registration demanded by others. 
 (2) The Holder will be subject to the same provisions regarding indemnification and market stand-off agreements as contained in the Investor Rights Agreement. 

(3) The registration rights are freely assignable by the Holder in connection with a permitted transfer of this Warrant or the Shares.

 12. Notice Rights. Unless otherwise set forth below, the Company agrees to give Holder at least twenty
(20) days prior written notice (or such shorter period of prior notice as the Company shall provide to the other holders of the Series C-2 Preferred Stock or Common Stock consistent with the Company’s Charter) of the events set forth
below. All notices in this Section must set forth details of the event, how the event adjusts either the Shares or the Exercise Price and the method used for such adjustment. 
 (a) Acquisition Transactions. The Company shall provide the Holder with the terms and conditions of any Merger Event. 
 (b) Dividends and Repurchases. The Company shall provide the Holder with at least ten (10) days notice prior to the record date of any dividend or distribution with respect to or offer to
repurchase the Applicable Stock. 
 (c) Initial Public Offering. If the Company has an initial public offering.

  

					
		  	-11-	  	WARRANT (TriplePoint)

 (d) Rights Offering. If the Company offers additional stock or other rights to the
existing stockholders for subscription pro-rata. 
 (e) Liquidation. The Company shall provide the Holder with at least
ten (10) days notice prior to any voluntary or involuntary dissolutions, liquidation or winding-up of the Company. 

13. Representations and Warranties. The Company represents and warrants to the Holder as follows: 

(a) The Company’s execution and delivery of this Warrant and the performance of the Company’s obligations hereunder, including
the issuance to Holder of the right to acquire the Shares, have been duly authorized by all necessary corporate action on the Company’s part and this Warrant constitutes a legal, valid and binding obligation of the Company enforceable in
accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and the rules of law or principles at equity governing specific performance, injunctive relief and other equitable
remedies. 
 (b) The Shares have been duly authorized and reserved for issuance by the Company and, when issued in accordance
with the terms hereof, will be validly issued, fully paid and nonassessable and free from preemptive rights. 
 (c) The rights,
preferences, privileges and restrictions granted to or imposed upon the Applicable Stock and the holders thereof are as set forth in the Charter, and on the Warrant Date, each share of the Applicable Stock represented by this Warrant is convertible
into one share of Common Stock. 
 (d) The shares of Common Stock issuable upon conversion of the Shares have been duly
authorized and reserved for issuance by the Company and, when issued in accordance with the terms of the Charter will be validly issued, fully paid and nonassessable. 
 (e) The execution and delivery of this Warrant are not, and the issuance of the Shares upon exercise of this Warrant in accordance with the terms hereof will not be, inconsistent with the Company’s
Charter or by-laws, do not and will not contravene any law, governmental rule or regulation, judgment or order applicable to the Company, and do not and will not conflict with or contravene any provision of, or constitute a default under, any
indenture, mortgage, contract or other instrument of which the Company is a party or by which it is bound or require the consent or approval of, the giving of notice to, the registration or filing with or the taking of any action in respect of or
by, any Federal, state or local government authority or agency or other person, except for the filing of notices pursuant to federal and state securities laws, which filings will be effected by the time required thereby. 

(f) There are no actions, suits, audits, investigations or proceedings pending or, to the knowledge of the Company, threatened against
the Company in any court or before any governmental commission, board or authority which, if adversely determined, could have a material adverse effect on the ability of the Company to perform its obligations under this Warrant. 

  

					
		  	-12-	  	WARRANT (TriplePoint)

 (g) All outstanding shares of Common Stock and preferred stock were issued in full
compliance with all Federal and state securities laws. In addition as of the Warrant Date: 
 (i) The Company’s authorized
capital consists of (A) 70,000,000 shares of Common Stock, of which 10,550,605 shares of Common Stock are issued and outstanding, and (B) 45,304,918 shares of preferred stock, of which 43,542,403 shares are issued and outstanding.

 (ii) The number of shares of Common Stock of the Company outstanding on the date hereof, on a fully diluted basis (assuming
the conversion of all outstanding convertible securities and the exercise of all outstanding options and warrants), does not exceed 67,646,622 shares. 
 (iii) The Company has reserved 13,078,694 shares of Common Stock for issuance under the Company’s Stock Incentive Plan, under which 8,749,302 options have been granted and are outstanding. Except as
otherwise provided in this Warrant and as noted above, there are no other options, warrants, conversion privileges or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued shares of Company capital stock or
other Company securities. 
 (h) Except as set forth in the Company Investor’s Rights Agreement, a true, correct and
complete copy of which has been delivered to Holder prior to the issuance of this Warrant, Company stockholders do not have preemptive rights to purchase new issuances of Company capital stock. 

(i) Except as set forth in this Warrant and the Investors’ Rights’ Agreement, the Company is not, pursuant to the terms of any
other agreement currently in existence, under any obligation to register under the 1933 Act any of the Company’s presently outstanding securities or any Company securities which may hereafter be issued. 

(j) Subject to the accuracy of Holder’s representations in the Warrant Purchase Agreement dated as of the date hereof, the issuance
of the Shares upon exercise of this Warrant will constitute a transaction exempt from (i) the registration requirements of Section 5 of the 1933 Act, in reliance upon Section 4(2) thereof, and (ii) the qualification requirements
of the applicable state securities laws. 
 (k) The Holder may sell the Shares issuable hereunder in compliance with Rule 144
promulgated by the Securities and Exchange Commission. Within ten (10) days of Holder’s request, the Company agrees to furnish Holder a written statement confirming Holder’s compliance with the filing requirements of the Securities
and Exchange Commission as set forth in such Rule 144, as may be amended. 
 14. Information Rights. 

(a) Financial Information. The Company shall provide to the Holder the financial statements specified in this Section 14
prepared in accordance with generally accepted accounting principles, consistently applied (except, in the case of unaudited financial statements, for the absence of footnotes and normal year-end adjustments); provided, however, that after the

  

					
		  	-13-	  	WARRANT (TriplePoint)

 
effective date of the initial registration statement covering a public offering to the Company’s securities, the Company shall only be required to deliver those financial statements required
to be filed by the Securities and Exchange commission, to be provided as soon as practicable and no less frequently than quarterly. As soon as practicable (and in any event within 45 days after the end of each fiscal quarter, an unaudited balance
sheet as of the end of such fiscal quarter and unaudited statements of income or loss, retained earnings or deficit, cash flows and capital structure of the Company for such quarter, certified by the Company’s Chief Executive Officer or Chief
Financial Officer to fairly present in all material respects the data reflected therein. As soon as practicable (and in any event within 180 days after the end of each fiscal year, audited balance sheets as of the end of such year (consolidated if
applicable) and related statements of income or loss, retained earnings or deficit, cash flows and capital structure of the Company for such year, setting forth in comparative form the corresponding figures for the preceding fiscal year, and
accompanied by an audit report and unqualified opinion of the independent certified public accountants of recognized national or regional standing selected by the Company. 
 (b) Equity Financing Information. Within fifteen (15) Business Days after the closing of any equity financing, or extension of an existing round of equity financing, occurring after the
Warrant Date, in which the Company issues preferred stock or other securities the Company will provide Holder with copies of the fully executed equity financing documents, including without limitation the related stock purchase agreement, investors
rights agreement, voting agreement, amended or restated certificates of incorporation, current capitalization table and other related documents. Notwithstanding any term or condition contained in this Warrant or the Loan Agreement to the contrary,
the Company’s failure to comply with this paragraph shall not constitute a default unless the Company has not provided the information requested within ten (10) days of Holder’s request. 

(c) 409A Material. Promptly upon Holder’s request, after its completion, the Company shall provide Holder with any 409A
Valuation Reports or other similar reports prepared for the Company. 
 (d) Additional Information. The Company shall
submit to Holder any other documents and other information that the Holder may reasonably request from time to time and are necessary to implement the provisions and purposes of this Warrant. 

15. Deliverables. Upon execution of this Warrant, the Company will provide the Holder with: 

(a) executed originals of this Warrant, and all other documents and instruments that Holder may reasonably require; 

(b) a Secretary’s certificate of incumbency and authority; 
 (c) certified copy of resolutions of the Company’s Board of Directors approving this Warrant; 
 (d) certified copy of Charter and By-Laws as amended through the Warrant Date; and 

  

					
		  	-14-	  	WARRANT (TriplePoint)

 (e) a current Investor’s Rights Agreement. 

16. Modification and Waiver. This Warrant and any provision hereof may be changed, waived, discharged or terminated only by
an instrument in writing signed by the party against which enforcement of the same is sought. 
 17. Notices. Any
notice, request, communication or other document required or permitted to be given or delivered to the Holder or the Company shall be delivered, or shall be sent by certified or registered mail, postage prepaid, or overnight courier or delivered
personally to the Holder at its address as shown on the books of the Company or to the Company at the address indicated therefor on the signature page of this Warrant. 
 18. Binding Effect on Successors. This Warrant shall be binding upon any corporation succeeding the Company by merger, consolidation or acquisition of all or substantially all of the
Company’s assets, and all of the obligations of the Company relating to the Applicable Stock issuable upon the exercise or conversion of this Warrant shall survive the exercise, conversion and termination of this Warrant and all of the
covenants and agreements of the Company shall inure to the benefit of the successors and assigns of the Holder. 
 19.
Lost Warrants or Stock Certificates. The Company covenants to the Holder that, upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant or any stock certificate and, in
the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the Company, or in the case of any such mutilation upon surrender and cancellation of such Warrant or stock certificate, the Company will make
and deliver a new Warrant or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant or stock certificate. 
 20. Descriptive Headings. The descriptive headings of the various Sections of this Warrant are inserted for convenience only and do not constitute a part of this Warrant. The language in
this Warrant shall be construed as to its fair meaning without regard to which party drafted this Warrant. 
 21.
Governing Law. This Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the State of California without giving effect to that body of law pertaining to conflicts of
laws. 
 22. Consent to Jurisdiction and Venue. All judicial proceedings arising in or under or related to this
Warrant may be brought in any state or federal court of competent jurisdiction located in the State of California. By execution and delivery of this agreement, each party hereto generally and unconditionally: (a) consents to personal
jurisdiction in San Mateo County, State of California; (b) waives any objection as to jurisdiction or venue in San Mateo County, State of California; (c) agrees not to assert any’ defense based on lack of jurisdiction or venue in the
aforesaid courts; and (d) irrevocably agrees to be bound by any judgment rendered thereby in connection with this Warrant. Service of process on any party hereto in any action arising out of or relating to this Warrant shall be effective if
given in accordance with the requirements for notice set forth in this Section, and shall be deemed effective and received as set forth therein. 

  

					
		  	-15-	  	WARRANT (TriplePoint)

 
Nothing herein shall affect the right to serve process in any other manner permitted by law or shall limit the right of either party to bring proceedings in the courts of any other jurisdiction.

 23. Mutual Waiver of Jury Trial; Judicial Reference. Because disputes arising in connection with complex
financial transactions are most quickly and economically resolved by an experienced and expert person and the parties wish applicable state and federal laws to apply (rather than arbitration rules), The parties desire that their disputes be resolved
by a judge applying such applicable laws. EACH OF THE PARTIES SPECIFICALLY WAIVES ANY RIGHT THEY MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM (COLLECTIVELY,
“CLAIMS”) ASSERTED BY THE COMPANY AGAINST HOLDER OR HOLDER’S ASSIGNEE OR BY HOLDER OR HOLDER’S ASSIGNEE AGAINST THE COMPANY. IN THE EVENT THAT THE FOREGOING JURY TRIAL WAIVER IS NOT ENFORCEABLE, ALL CLAIMS, INCLUDING ANY AND ALL
QUESTIONS OF LAW OR FACT RELATING THERETO, SHALL, AT THE WRITTEN REQUEST OF ANY PARTY, BE DETERMINED BY JUDICIAL REFERENCE PURSUANT TO THE CALIFORNIA CODE OF CIVIL PROCEDURE (“REFERENCE”). THE PARTIES SHALL SELECT A SINGLE NEUTRAL REFEREE,
WHO SHALL BE A RETIRED STATE OR FEDERAL JUDGE. IN THE EVENT THAT THE PARTIES CANNOT AGREE UPON A REFEREE, THE REFEREE SHALL BE APPOINTED BY THE COURT. THE REFEREE SHALL REPORT A STATEMENT OF DECISION TO THE COURT. NOTHING IN THIS SECTION SHALL LIMIT
THE RIGHT OF ANY PARTY AT ANY TIME TO EXERCISE LAWFUL SELF-HELP REMEDIES, FORECLOSE AGAINST COLLATERAL OR OBTAIN PROVISIONAL REMEDIES. THE PARTIES SHALL BEAR THE FEES AND EXPENSES OF THE REFEREE EQUALLY UNLESS THE REFEREE ORDERS OTHERWISE. THE
REFEREE SHALL ALSO DETERMINE ALL ISSUES RELATING TO THE APPLICABILITY, INTERPRETATION, AND ENFORCEABILITY OF THIS SECTION. THE PARTIES ACKNOWLEDGE THAT THE CLAIMS WILL NOT BE ADJUDICATED BY A JURY. This waiver extends to all such Claims, including
Claims that involve Persons other than the Company and Holder; Claims that arise out of or are in any way connected to the relationship between the Company and Holder; and any Claims for damages, breach of contract, specific performance, or any
equitable or legal relief of any kind, arising out of this Warrant Agreement. 
 24. Survival of Representations,
Warranties and Agreements. All representations, warranties, covenants and conditions of the Company and the Holder contained herein shall survive the Warrant Date, the exercise or conversion of this Warrant (or any part hereof) or the
termination or expiration of rights hereunder. All agreements of the Company and the Holder contained herein shall survive indefinitely until, by their respective terms, they are no longer operative. 

25. Remedies. In case any one or more of the covenants and agreements contained in this Warrant shall have been breached,
the Holder (in the case of a breach by the Company), or the Company (in the case of a breach by the Holder), may proceed to protect and enforce their or its rights either by suit in equity and/or by action at law, including, but not limited to, an
action for damages as a result of any such breach and/or an action for specific performance for any breach of any such covenant or agreement contained in this Warrant where such party will not have an adequate remedy at law and where damages will
not be readily ascertainable. Each 

  

					
		  	-16-	  	WARRANT (TriplePoint)

 
party expressly acknowledges and agrees that there is no adequate remedy at law for any breach of this Warrant and that in the event of any breach of this Warrant, the injured party shall be
entitled to specific performance of any or all provisions hereof or an injunction prohibiting the other party from continuing to commit any such breach of this Warrant. 
 26. No Impairment of Rights. The Company will not, by amendment of its Charter or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by the Company, but will at all times in good faith assist in carrying out of all the
provisions of this Warrant and in taking all such action as may be necessary or appropriate to protect the rights of the Holder under this Warrant against impairment. Notwithstanding the foregoing, the Company shall not be deemed to have impaired
the rights of the Holder with any amendment of the Company’s Charter or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, if such amendment or
transaction affects the rights, privileges, preferences of the securities then issuable upon exercise of this Warrant in a manner that is not different from the effect on the outstanding securities of the Company that are of the same series and
class as the Shares. 
 27. Severability The invalidity or unenforceability of any provision of this Warrant in
any jurisdiction shall not affect the validity or enforceability of such provision in any other jurisdiction, or affect any other provision of this Warrant, which shall remain in full force and effect. In the event any one or more of the provisions
of this Warrant Agreement shall for any reason be held invalid, illegal or unenforceable, the remaining provisions of this Warrant shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable
valid, legal and enforceable provision, which comes closest to the intention of the parties underlying the invalid, illegal or unenforceable provision. 
 28. Recovery of Litigation Costs. If any legal action or other proceeding is brought for the enforcement of this Warrant, or because of an alleged dispute, breach, default, or
misrepresentation in connection with any of the provisions of this Warrant, the successful or prevailing party or parties shall be entitled to recover reasonable attorneys’ fees and other costs incurred in that action or proceeding, in addition
to any other relief to which it or they may be entitled. 
 29. Entire Agreement; Modification. This Warrant
constitutes the entire agreement between the parties pertaining to the subject matter contained in it and supersedes all prior and contemporaneous agreements, representations, and undertakings of the parties, whether oral or written, with respect to
such subject matter. 
 30. Counterparts. This Warrant Agreement may be executed in two or more counterparts, each
of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 31.
Electonic/Facsimile Signatures. This Warrant may be executed and delivered by facsimile or electronically in PDF or similar format and upon such delivery the facsimile or 

  

					
		  	-17-	  	WARRANT (TriplePoint)

 
electronic signature will be deemed to have the same effect as if the original signature had been delivered to the other party. 

  

					
		  	-18-	  	WARRANT (TriplePoint)

 The Company has caused this Warrant to be duly executed and delivered as of the Warrant Date
specified above. 
  

			
	CHEGG, INC.
		
	By	 	 /s/ Omer Regev

		
	Title	 	 CFO

		
	Address:	 	2350 Mission College Blvd. Suite 1400 Santa Clara, CA 95054

  

					
		  	-19-	  	WARRANT (TriplePoint)

 EXHIBIT A 
 NOTICE OF EXERCISE 
  

	To:	Chegg, Inc. (the “Company”) 

  

	 	1.	The undersigned hereby: 

  

	 	 ̈	elects to purchase              shares of [Applicable Stock] [Common Stock] of the Company pursuant
to the terms of the attached Warrant, and tenders herewith payment of the purchase price of such shares in full, or 

  

	 	 ̈	elects to exercise its net issuance rights pursuant to Section 3(b) of the attached Warrant with respect to
             Shares of [Applicable Stock] [Common Stock]. 

  

	 	2.	Please issue a certificate or certificates representing              shares in the name of the
undersigned or in such other name or names as are specified below: 

  

					
		  	  
	  	
		  	(Name)	  	
		  		  	
		  	  
	  	
		  	  
	  	
		  	(Address)	  	

  

	 	3.	The undersigned represents that the aforesaid shares are being acquired for the account of\ the undersigned for investment and not with a view to, or for resale in
connection with, the distribution thereof and that the undersigned has no present intention of distributing or reselling such shares, all except as in compliance with applicable securities laws. 

 

			
	[TRIPLEPOINT CAPITAL LLC]
		
	By	 	
		
	Title	 	  

  

					
	  
	 		 	
	 (Date)
	 		 	

 EXHIBIT B 
 NOTICE OF EXERCISE 
  

	To:	Chegg, Inc. (the “Company”) 

 1. Contingent upon and effective immediately prior to the closing (the “Closing”) of the Company’s public offering contemplated by the Registration Statement on Form S
            , filed             , 200    , the undersigned hereby: 

 ̈ elects to purchase
             shares of [Applicable Stock] [Common Stock] of the Company (or such lesser number of shares as may be sold on behalf of the undersigned at the Closing) pursuant to the
terms of the attached Warrant, or 
  ̈ elects to exercise its net issuance
rights pursuant to Section 3(b) of the attached Warrant with respect to              Shares of [Applicable Stock] [Common Stock]. 

2. Please deliver to the custodian for the selling stockholders a stock certificate representing such
             shares. 
 3. The undersigned has instructed the
custodian for the selling stockholders to deliver to the Company $             or, if less, the net proceeds due the undersigned from the sale of shares in the aforesaid public
offering. If such net proceeds are less than the purchase price for such shares, the undersigned agrees to deliver the difference to the Company prior to the Closing. 

 

			
	[TRIPLEPOINT CAPITAL LLC]
		
	By	 	
		
	Title	 	  

  

					
	  
	 		 	
	 (Date)
	 		 	

 EXHIBIT C 
 ACKNOWLEDGMENT OF EXERCISE 
 Chegg, Inc. hereby acknowledges receipt of the “Notice of
Exercise” from [                    ] to purchase [            ]
shares of the Series [            ] Preferred Stock of [            ], pursuant to the terms of the Warrant,
and further acknowledges that [            ] shares remain subject to purchase under the terms of the Warrant. 

 

			
	CHEGG, INC.
		
	By:	 	  

		
	Title:	 	  

		
	Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]